LIFT: Life Improvement Trial

NCT06366724 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

160

Enrollment

OTHER

Sponsor class

Conditions

ME/CFS
Long COVID
PASC

Interventions

DRUG: Pyridostigmine
DRUG: Low-Dose Naltrexone
OTHER: Placebo

Sponsor

Brigham and Women's Hospital

Collaborators

[object Object]